Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein, CF

Catalog # Availability Size / Price Qty
10108-B7-050
Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein Inhibition Activity
2 Images
Product Details
FAQs
Reviews

Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein, CF Summary

Product Specifications

Purity
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<1.0 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to inhibit anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 1-6 μg/mL.
Source
Human embryonic kidney cell, HEK293-derived cynomolgus monkey B7-H7/HHLA2 protein
Cynomolgus Monkey
B7-H7
(Ile21-Asn345)
Accession # XP_005548285
IEGRMD Human IgG1
(Pro100-Lys330)
N-terminusC-terminus
Accession #
N-terminal Sequence
Analysis
Ile21
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
64 kDa
SDS-PAGE
92-109 kDa, reducing conditions

Product Datasheets

You must select a language.

x

10108-B7

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

10108-B7

Formulation Lyophilized from a 0.2 μm filtered solution in Citric Acid and NaCl with Trehalose.
Reconstitution Reconstitute at 200 μg/mL in water.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Inhibition Activity Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein Inhibition Activity View Larger

Recombinant Cynomolgus Monkey B7-H7/HHLA2 Fc Chimera (Catalog # 10108-B7) inhibits anti-CD3 antibody induced IL-2 secretion in human T lymphocytes. The ED50 for this effect is 1-6 μg/mL.

SDS-PAGE Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein SDS-PAGE View Larger

1 μg/lane of Recombinant Cynomolgus Monkey B7-H7/HHLA2 Fc Chimera (Catalog # 10108-B7) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing bands at 92-109 kDa and 180-220 kDa, respectively.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: B7-H7/HHLA2

B7-H7, also known as HHLA2 (HERV-H LTR-associating protein 2), is a member of the B7 family of immune regulatory proteins (1, 2). The mature human B7-H7 protein consists of a 322 amino acid (aa) extracellular domain (ECD) with three immunoglobulin-like domains, a 21 aa transmembrane segment, and a 49 aa cytoplasmic domain (3-5). Within the ECD, cynomolgus B7-H7 shares 90% aa sequence identity with human B7-H7. It is constitutively expressed on monocytes and is up-regulated by LPS and IFN-gamma stimulation. It is expressed on LPS/IFN-gamma treated B cells but not on resting B cells (5). B7-H7 binds to cell surface determinants on resting and mature T cells, B cells, and monocytes as well as on immature and mature dendritic cells (5). The receptor TMIGD2, commonly found in endothelial and epithelial cells, has also been identified as one of the receptors for B7-H7 (6). Soluble B7-H7 inhibits the proliferation of activated CD4+ and CD8+ T cells and their production of IFN-gamma, TNF-alpha, IL-5, IL-10, IL-13, IL-17A, and IL-22 (5).

References
  1. Zou, W. and L. Chen (2008) Nat. Rev. Immunol. 8:467.
  2. Bour-Jordan, H. et al. (2011) Immunol. Rev. 241:180.
  3. Mager, D.L. et al. (1999) Genomics 59:255.
  4. Flajnik, M.M. et al. (2012) Immunogenetics 64:571.
  5. Zhao, R. et al. (2013) Proc. Natl. Acad. Sci. USA 110:9879.
  6. Janakiram, M. et al. (2015) OncoImmunology 4:e1026534-1
Long Name
B7 Homolog 7
Entrez Gene IDs
11148 (Human); 102137704 (Cynomolgus Monkey)
Alternate Names
B7H7; B7-H7; HERV-H LTR-associating 2; HERV-H LTR-associating protein 2; HHLA2; Human endogenous retrovirus-H long terminal repeat-associating protein 2

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein, CF and earn rewards!

Have you used Recombinant Cynomolgus B7-H7/HHLA2 Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review